TLRY Stock Overview
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Tilray Brands, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.22 |
| 52 Week High | US$2.56 |
| 52 Week Low | US$1.22 |
| Beta | 2.19 |
| 11 Month Change | -16.30% |
| 3 Month Change | -27.88% |
| 1 Year Change | -25.14% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -54.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| TLRY | AT Pharmaceuticals | AT Market | |
|---|---|---|---|
| 7D | -12.1% | -3.0% | 1.1% |
| 1Y | -25.1% | 4.3% | 1.2% |
Return vs Industry: TLRY underperformed the Austrian Pharmaceuticals industry which returned 3.6% over the past year.
Return vs Market: TLRY underperformed the Austrian Market which returned 1.1% over the past year.
Price Volatility
| TLRY volatility | |
|---|---|
| TLRY Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.5% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: TLRY's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: TLRY's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,650 | Irwin Simon | www.tilray.com |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products.
Tilray Brands, Inc. Fundamentals Summary
| TLRY fundamental statistics | |
|---|---|
| Market cap | €1.12b |
| Earnings (TTM) | -€201.73m |
| Revenue (TTM) | €770.46m |
1.4x
P/S Ratio-5.5x
P/E RatioIs TLRY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TLRY income statement (TTM) | |
|---|---|
| Revenue | US$812.04m |
| Cost of Revenue | US$565.88m |
| Gross Profit | US$246.16m |
| Other Expenses | US$458.78m |
| Earnings | -US$212.62m |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 30.31% |
| Net Profit Margin | -26.18% |
| Debt/Equity Ratio | 9.2% |
How did TLRY perform over the long term?
See historical performance and comparison